Adverse Drug Reactions and Drug Delivery

webinar

Thu, 30 Nov 2023, 16:00 CET (Berlin)

Prof. Dr. Laleh Alisaraie, Memorial University of Newfoundland, Canada

Adverse Drug Reactions and Drug Delivery

Adverse drug reactions (ADRs) are not only a significant concern in public health but also one of the main challenges in drug discovery. This is especially true for anti-cancer drug development, which is slow and costly; ADRs can also be the cause of drug withdrawals from the market. The interactions of anti-cancer drugs at off-target sites in the body may result in a wide range of undesired effects that occur through complex biological mechanisms and may turn out severe enough so that they result in hospital admissions. A suitable drug delivery system cannot only improve the effectiveness of a drug but also serve to reduce its adverse reactions.

In this BioSolveIT Webinar, Laleh will discuss case studies, where the application of computational simulations has aided. This covers the analysis of a drug mechanism of action at potential off-target sites, or designing and evaluating specific drug delivery systems to mitigate the unwanted impact of chemotherapeutic agents.

Join us for an interesting twist on computational drug discovery methods and vivid discussions!

Current news

CHEMriya Update November
November 11, 2026 11:19 CET
More Chemistry. More Possibilities. The latest update of CHEMriya brings over 794 billion virtual product molecules to your compound exploration. Developed by OTAVA in collaboration with BioSolveIT, this on-demand Chemical Space opens up new opportunities for hit expansion, hit-to-lead optimization, and compound evolution. The November 2026 release combines OTAVA’s chemistry...
Read on
category
Challenge
Winter 2026 Scientific Challenge Deadline Approaching
November 3, 2026 13:18 CET
The Winter 2026 Scientific Challenge is here! We invite researchers from academia (students, postdocs, and professors), non-profit organizations, and independent researchers to take part. Whether you are exploring a new drug discovery idea or looking to advance an existing project, our software can help you take your research further. How...
Read on
CORE by Onepot.AI – Access now with our tools
October 27, 2026 14:38 CET
Bringing Robotic Synthesis to Chemical Space Exploration A new Chemical Space is now available for your compound exploration: onepot’s CORE Space brings over 10 billion virtual product molecules to your drug discovery projects. CORE (Compounds On-demand via Robotic Execution) combines reactions widely used in medicinal chemistry with building blocks that...
Read on